Raffaella Marocco

Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia

Maria Antonella Zingaropoli, Parni Nijhawan, Anna Carraro et al. · Frontiers in Immunology · 2021 · 225 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II)

Ernesto Maddaloni, Luca D’Onofrio, Francesco Alessandri et al. · Cardiovascular Diabetology · 2020 · 114 citations · Full text

Medicine, Internal Medicine, Critical Care Cardiology +11

Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

Maria Carmela Piccirillo, Paolo A. Ascierto, Carlo Salvarani et al. · Journal of Translational Medicine · 2020 · 112 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

In Vivo and In Vitro Effects of Antituberculosis Treatment on Mycobacterial Interferon-γ T Cell Response

Ilaria Sauzullo, Fabio Mengoni, Miriam Lichtner et al. · PLoS ONE · 2009 · 54 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon

Claudia Mascia, Serena Vita, Paola Zuccalà et al. · PLoS ONE · 2017 · 49 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16